Daily Stock Analysis, ANGO, AngioDynamics Inc, priceseries

AngioDynamics Inc. Daily Stock Analysis
Stock Information
Open
26.99
Close
25.31
High
27.11
Low
25.04
Previous Close
26.97
Daily Price Gain
-1.66
YTD High
30.25
YTD High Date
Jul 13, 2021
YTD Low
14.96
YTD Low Date
Jan 4, 2021
YTD Price Change
9.87
YTD Gain
63.92%
52 Week High
30.25
52 Week High Date
Jul 13, 2021
52 Week Low
9.37
52 Week Low Date
Sep 18, 2020
52 Week Price Change
15.34
52 Week Gain
153.86%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 2. 2018
17.42
Apr 23. 2018
19.61
15 Trading Days
12.57%
Link
LONG
Jan 31. 2019
21.10
Feb 21. 2019
22.51
14 Trading Days
6.66%
Link
LONG
Jun 28. 2019
19.69
Jul 19. 2019
21.24
14 Trading Days
7.87%
Link
LONG
Sep 25. 2020
10.05
Oct 12. 2020
11.47
11 Trading Days
14.14%
Link
LONG
Nov 5. 2020
11.35
Dec 11. 2020
14.57
25 Trading Days
28.38%
Link
LONG
Dec 30. 2020
14.63
Jan 22. 2021
17.61
15 Trading Days
20.37%
Link
LONG
Feb 4. 2021
19.60
Feb 18. 2021
20.63
9 Trading Days
5.24%
Link
Company Information
Stock Symbol
ANGO
Exchange
NasdaqGS
Company URL
http://www.angiodynamics.com
Company Phone
5187981215
CEO
James C. Clemmer
Headquarters
New York
Business Address
14 PLAZA DRIVE, LATHAM, NY 12110
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001275187
About

AngioDynamics, Inc. engages in the business of medical devices. Its activities include design, manufactures, and sale of medical, surgical and diagnostic devices. The company focuses on devices in the field of vascular access, peripheral vascular, oncology, and surgery. AngioDynamics was founded by Eamonn P. Hobbs in 1988 and is headquartered in Latham, NY.

Description

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for vascular access, surgery, peripheral vascular disease, and oncology in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides microwave ablation products; radiofrequency ablation products for ablating solid cancerous or benign tumors; and NanoKnife ablation systems for the surgical ablation of soft tissues. AngioDynamics, Inc. sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.